$5.07 0.13 (+2.63%)
11/25/2009 11:13 AM

Cytori Therapeutics, Inc. (USA) (CYTX)

CAPS Rating: 4 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Featured Broker Partners